Science Explorer Back to mapMap
Discussion
Researcher · National Cancer Institute · United States

Nicholas P. Restifo

Nicholas P. Restifo publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, CAR-T cell therapy research and Immune Cell Function and Interaction.

ORCID 0000-0003-4229-4580 OpenAlex
World rank
#6,753
of 7,710,434 ranked researchers
Rank in United States
#2,324
of 1,627,098
Works
672
Citations
98k
Citations per work
146.5
h-index
151
i10-index 362Top 0.1% in Immunology
Nicholas P. Restifo

What does Nicholas P. Restifo research?

Nicholas P. Restifo's work is mostly in Immunology and Microbiology (47%), Medicine (26%), Biochemistry, Genetics and Molecular Biology (19%).

Life Sciences: 449 works · 66.8% of their workImmunology and Microbiology: 319 works · 47.4% of their workImmunology: 319 works · 47.4% of their workBiochemistry, Genetics and Molecular Biology: 130 works · 19.4% of their workMolecular Biology: 75 works · 11.2% of their workGenetics: 42 works · 6.3% of their workBiotechnology: 13 works · 1.9% of their workHealth Sciences: 172 works · 25.6% of their workMedicine: 172 works · 25.6% of their workOncology: 163 works · 24.3% of their workEpidemiology: 9 works · 1.3% of their workEverything else: 51 works · 7.6% of their workTHEIR WORKNicholas P.Restifo672works
Life Sciences67%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology31947.4%
    2. Biochemistry, Genetics and Molecular Biology13019.4%
    1. Medicine17225.6%
  3. Everything else517.6%
  1. 1Immunology47% of their works
  2. 2Oncology24% of their works
  3. 3Molecular Biology11% of their works
  4. 4Genetics6% of their works
  5. 5Biotechnology2% of their works
  6. 6Epidemiology1% of their works

Research topics

Which keywords describe Nicholas P. Restifo's research?

The keywords of their largest research topics: Cancer Immunotherapy, Antigen Presentation, Dendritic Cells, Immunity, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy5212 topics
  2. Antigen Presentation3452 topics
  3. Dendritic Cells2961 topic
  4. Immunity2961 topic
  5. CAR T Cells2251 topic
  6. Chimeric Antigen Receptor2251 topic
  7. NK Cell Recognition1741 topic
  8. Natural Killer Cells1741 topic
  9. Foxp31261 topic
  10. TGF-ß1261 topic
  11. Gene Therapy1102 topics
  12. Immune Checkpoint Blockade861 topic
  13. PD-1 and PD-L1861 topic
  14. AAV831 topic
  15. Viral Vectors831 topic
  16. Epitope Prediction491 topic
  17. Peptide-MHC Binding491 topic
  18. RNA Interference271 topic
  19. siRNA Delivery271 topic

Where does Nicholas P. Restifo work?

Nicholas P. Restifo's main affiliation in the publication record is National Cancer Institute, United States.

How many publications and citations does Nicholas P. Restifo have?

OpenAlex counts 672 works and 98,432 citations for Nicholas P. Restifo, an h-index of 151, ranking #6,753 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nicholas P. Restifo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.